Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study
Crossref DOI link: https://doi.org/10.1136/rmdopen-2018-000762
Published Online: 2018-10-15
Published Print: 2018-10
Update policy: https://doi.org/10.1136/crossmarkpolicy
Lindström, Ulf https://orcid.org/0000-0002-2250-9348
Olofsson, Tor
Wedrén, Sara
Qirjazo, Ilia
Askling, Johan
Funding for this research was provided by:
Karolinska Institutet